Literature DB >> 20056166

Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii.

Feng Tan1, Xin Hu, Chang-Wang Pan, Jie-Qiong Ding, Xiao-Guang Chen.   

Abstract

Nucleoside triphosphate hydrolase (NTPase) is an abundant protein secreted by the obligate protozoan parasite Toxoplasma gondii, which has a wide specificity toward NTP. In the present study, two monoclonal antibodies (mAbs, MNT1 and MNT2) against recombinant T. gondii NTPase-II (rTgNTPase-II) were developed. Western blot analysis displayed that these two mAbs can recognize specifically rTgNTPase-II as well as a 63kDa molecule in tachyzoites soluble antigens that corresponded to native NTPase-II. T. gondii tachyzoites pretreated with two mAbs were observed under Confocal Laser Microscope and a specific reaction was displayed on tachyzoites after indirect fluorescence antibody test (IFAT). When COS-7 cells were co-cultured with tachyzoites pretreated with two mAbs, the number of intracellular parasites per infected cell was significantly decreased compared with the control. Furthermore, incubation of T. gondii tachyzoites with two mAbs can inhibit NTPase activity in the presence of dithiothreitol, which hinted that the reduction of tachyzoite replication might be owing to the inhibition of NTPase-II by the mAbs. The passive immunization test indicated that the transferred mAbs can significantly prolong the survival time of challenge infected mice. Taken together, we concluded that the mAbs against NTPase-II can reduce the replication of T. gondii and have a crucial effect on the protection of host from T. gondii infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056166     DOI: 10.1016/j.parint.2009.12.007

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  11 in total

1.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

Review 2.  Antibody-based vaccine strategies against intracellular pathogens.

Authors:  Arturo Casadevall
Journal:  Curr Opin Immunol       Date:  2018-04-25       Impact factor: 7.486

3.  An antigenic domain of the Leishmania amazonensis nucleoside triphosphate diphosphohydrolase (NTPDase 1) is associated with disease progression in susceptible infected mice.

Authors:  M L Detoni; M R Fessel; A C R G Maia; G N Porcino; L R Quellis; P Faria-Pinto; M J Marques; M A Juliano; L Juliano; V A Diniz; S Côrte-Real; S C Gonçalves-da-Costa; C S F Souza; E G Vasconcelos
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

4.  Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Silvia Gómez-Sebastián; Carmen Nuñez; Carmen Alvarado; Rodrigo Lasa; José M Escribano; Lorena L Garaicoechea; Fernando Fernandez; Karin Bok; Andrés Wigdorovitz; Linda J Saif; Viviana Parreño
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

Review 5.  Recent advances in Toxoplasma gondii immunotherapeutics.

Authors:  Sherene Swee-Yin Lim; Rofina Yasmin Othman
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

6.  Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis.

Authors:  Shuai Wang; Zhenchao Zhang; Yujian Wang; Javaid A Gadahi; Lixin Xu; Ruofeng Yan; Xiaokai Song; Xiangrui Li
Journal:  Front Microbiol       Date:  2017-02-13       Impact factor: 5.640

7.  Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).

Authors:  Fangjun Luo; Lina Zheng; Yue Hu; Shuxian Liu; Yan Wang; Zhongkui Xiong; Xin Hu; Feng Tan
Journal:  Front Microbiol       Date:  2017-04-05       Impact factor: 5.640

Review 8.  E-NTPDases: Possible Roles on Host-Parasite Interactions and Therapeutic Opportunities.

Authors:  Lisvane Paes-Vieira; André Luiz Gomes-Vieira; José Roberto Meyer-Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2021-11-09       Impact factor: 5.293

9.  A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis.

Authors:  Xiaowei Tian; Hanqi Sun; Meng Wang; Guangmin Wan; Tong Xie; Xuefang Mei; Zhenchao Zhang; Xiangrui Li; Shuai Wang
Journal:  Front Vet Sci       Date:  2022-02-15

Review 10.  Treatment of toxoplasmosis: Current options and future perspectives.

Authors:  Neda Konstantinovic; Hélène Guegan; Tijana Stäjner; Sorya Belaz; Florence Robert-Gangneux
Journal:  Food Waterborne Parasitol       Date:  2019-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.